share_log

多瑞医药:天健会计师事务所(特殊普通合伙)关于西藏多瑞医药股份有限公司2023年年报问询函的回复

Tibet Duo Rui Pharmaceutical: Response from Tianjian Certified Public Accountants (Special General Partnership) to the inquiry letter on the 2023 annual report of Tibet Dorui Pharmaceutical Co., Ltd.

Sensex a share ·  May 15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more